ArticleProstate cancer and prostatic diseases2026
Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.
Anita Csizmarik et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.